The Pathogenicity of Anti-<i>β</i>2GP1-IgG Autoantibodies Depends on Fc Glycosylation

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="center" colspan="2">SNA-ELISA</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Primary detection reagent</td><td align="left">Biotinylated SNA-lectin <br/>(Galab Technologies, Geesthacht, Germany)</td></tr><tr><td align="left">Secondary detection reagent</td><td align="left">HRP-conjugated streptavidin <br/>(Jackson ImmunoResearch laboratories, Newmarket, Suffolk, United Kingdom)</td></tr><tr><td align="left">Dilution</td><td align="left">1 : 10.000</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td>SNA = <i>Sambucus nigra</i> agglutinin; HRP = horseradish peroxidase.<br/></td></tr></table>

Journal of Immunology Research

tab2

Table 2

Table 2: The Pathogenicity of Anti-<i>β</i>2GP1-IgG Autoantibodies Depends on Fc Glycosylation 

Journal of Immunology Research

The Pathogenicity of Anti-β2GP1-IgG Autoantibodies Depends on Fc Glycosylation

Table 2